CoChat

BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: A promising neuroprotective strategy

Open access
Chabrier, Pierre-Etienne, Auguet, Michel, Spinnewyn, Brigitte, Auvin, Serge, Cornet, Sylvie, Demerlé-Pallardy, Caroline, Guilmard-Favre, Christine, Marin, Jean-Grégoire, Pignol, Bernadette, Gillard-Roubert, Véronique, Roussillot-Charnet, Christelle, Schulz, Jocelyne, Viossat, Isabelle, Bigg, Dennis, Moncada, Salvador · 1999 · Proceedings of the National Academy of Sciences
Cited by 123

The DOI matches its Crossref record.

Abstract

Nitric oxide (NO) and reactive oxygen species (ROS) act independently as well as cooperatively to induce neuronal death in acute neurological disorders. Inhibition of neuronal nitric oxide synthase (nNOS) and inhibition of lipid peroxidation induced by ROS have both been proposed as neuroprotective strategies in stroke and trauma. Recently, in our laboratory, the combination of the two strategies was found to be synergistic in reducing neuronal damage. Here, we report that BN 80933 [( S )- N -{4-[4-[(3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2 H -1-benzopyran-2-yl)carbonyl]-1-piperazinyl]phenyl}-2-thiophenecarboximidamide], a compound that combines potent antioxidant and selective nNOS inhibitory properties in vitro , affords remarkable neuronal protection in vivo . Intravenous administration of BN 80933 significantly reduced brain damage induced by head trauma in mice, global ischemia in gerbils, and transient focal ischemia in rats. Treatment with BN 80933 (0.3–10 mg/kg) significantly reduced infarct volume (>60% protection) and enhanced behavioral recovery in rats subjected to transient (2-h) middle cerebral artery occlusion and 48-h or 7-day reperfusion. Furthermore, treatment with BN 80933 commencing up to 8 h after the onset of ischemia resulted in a significant improvement of neurological outcome. All these results indicate that BN 80933 represents a class of potentially useful therapeutic agents for the treatment of stroke or trauma and possibly neurodegenerative disorders that involve both NO and ROS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.96.19.10824

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 123

Metadata

Authors
Chabrier, P.-E., Auguet, M., Spinnewyn, B., Auvin, S., Cornet, S., Demerlé-Pallardy, C., Guilmard-Favre, C., Marin, J.-G., Pignol, B., Gillard-Roubert, V., Roussillot-Charnet, C., Schulz, J., Viossat, I., Bigg, D., & Moncada, S.
Venue
Proceedings of the National Academy of Sciences
Published
1999-09-14
Volume
96
Issue
19
Pages
10824-10829
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2152384354
Cited by
123
References
0
FWCI
4.31
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: A promising neuroprotective strategy. https://app.cochat.ai/papers/10.1073/pnas.96.19.10824
The paper
Chabrier, P.-E., Auguet, M., Spinnewyn, B., Auvin, S., Cornet, S., Demerlé-Pallardy, C., Guilmard-Favre, C., Marin, J.-G., Pignol, B., Gillard-Roubert, V., Roussillot-Charnet, C., Schulz, J., Viossat, I., Bigg, D., & Moncada, S. (1999). BN 80933, a dual inhibitor of neuronal nitric oxide synthase and lipid peroxidation: A promising neuroprotective strategy. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.96.19.10824

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.